Related Experiment Video
Updated: Aug 5, 2026

In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
Increased Adrenergic Receptor Expression in Meniere Disease
Adam Y Xiao1, Achilles Kanaris1, Masanori Ishii2,3
1Department of Head and Neck Surgery, University of California, Los Angeles, CA.
Hypothesis:
There is increased expression of adrenergic receptors in the vestibular end organs of Meniere disease.
Background:
Meniere disease (MD) is an inner ear condition characterized by episodic vertigo, hearing loss, tinnitus, and aural fullness. It is believed to be due to an imbalance in inner ear fluid, often leading to hydrops; however, the exact mechanism is unclear. Pupillometry data have suggested a role for autonomic dysfunction, specifically sympathetic hyperactivity, but few studies have investigated the molecular pathways involved in this.
Methods:
Vestibular end organs from patients undergoing labyrinthectomy for MD (n=6), as well as control specimens (n=3) from patients with vestibular schwannoma undergoing translabyrinthine resection, were collected and processed for RNA in situ hybridization using the RNAscope Multiplex Fluorescent V2 Assay with probes for β 1 -, β 2 -, and α 1a -adrenergic receptors (AR). Positive and negative control experiments were also performed for quality control. Immunofluorescence was used to characterize protein expression of α 1a -AR and to identify vestibular hair cells (VHC) in the sensory epithelium (Myosin VIIa).
Results:
There is increased expression of α 1a -AR transcripts in MD utricles compared with control. This appears to be concentrated in the sensory epithelium VHC, confirmed with MyoVIIa positivity, although expression can be seen in the stroma as well. This was further confirmed with immunofluorescence, demonstrating increased expression in MD. There is also transcriptional expression of β 2 -AR with no difference between the 2 groups.
Conclusions:
There are limited molecular studies investigating the pathogenesis of MD, especially those utilizing human surgical tissue. This is the first study to demonstrate increased expression of α 1a -AR both at the transcriptional and protein levels in MD compared with controls. These results may help explain the mechanism behind sympathetic hyperactivity and guide future therapies.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
